A detailed history of First Light Asset Management, LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, First Light Asset Management, LLC holds 51,723 shares of ASND stock, worth $7.05 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
51,723
Previous 36,157 43.05%
Holding current value
$7.05 Million
Previous $4.93 Million 56.64%
% of portfolio
0.67%
Previous 0.45%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.0 - $153.43 $1.76 Million - $2.39 Million
15,566 Added 43.05%
51,723 $7.72 Million
Q2 2024

Aug 14, 2024

BUY
$121.07 - $153.67 $4.38 Million - $5.56 Million
36,157 New
36,157 $4.93 Million

Others Institutions Holding ASND

About Ascendis Pharma A/S


  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.61B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.